AU6941000A - Polypeptides that bind hiv gp120 and related nucleic acids, antibodies, compositions, and methods of use - Google Patents
Polypeptides that bind hiv gp120 and related nucleic acids, antibodies, compositions, and methods of useInfo
- Publication number
- AU6941000A AU6941000A AU69410/00A AU6941000A AU6941000A AU 6941000 A AU6941000 A AU 6941000A AU 69410/00 A AU69410/00 A AU 69410/00A AU 6941000 A AU6941000 A AU 6941000A AU 6941000 A AU6941000 A AU 6941000A
- Authority
- AU
- Australia
- Prior art keywords
- polypeptides
- antibodies
- compositions
- methods
- nucleic acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15127099P | 1999-08-27 | 1999-08-27 | |
US60/151270 | 1999-08-27 | ||
PCT/US2000/023505 WO2001016182A2 (fr) | 1999-08-27 | 2000-08-25 | Polypeptides de liaison a la glycoproteine gp120 du virus de l'immunodeficience humaine (vih), acides nucleiques, anticorps et compositions associes, et methodes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6941000A true AU6941000A (en) | 2001-03-26 |
Family
ID=22538016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69410/00A Abandoned AU6941000A (en) | 1999-08-27 | 2000-08-25 | Polypeptides that bind hiv gp120 and related nucleic acids, antibodies, compositions, and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6941000A (fr) |
WO (1) | WO2001016182A2 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1460088A1 (fr) | 2003-03-21 | 2004-09-22 | Biotest AG | Anticorps humanisé contre CD4 avec des caractéristiques immunosuppressives |
WO2009029716A1 (fr) * | 2007-08-28 | 2009-03-05 | Ramot At Tel Aviv University | Peptides induisant une configuration de type cd4i pour la protéine gp120 du vih tout en maintenant vacants des sites de liaison avec le récepteur cd4 |
ES2569217T3 (es) | 2008-03-13 | 2016-05-09 | Biotest Ag | Agente para tratar enfermedades |
AU2009224690B2 (en) | 2008-03-13 | 2014-10-09 | Biotest Ag | Agent for treating disease |
CN102202678A (zh) | 2008-11-04 | 2011-09-28 | 安科治疗公司 | Cxcr4受体化合物 |
WO2010092185A2 (fr) | 2009-02-16 | 2010-08-19 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Inhibiteurs de l'intération scramblase/cd4 pour le traitement d'infections à lentivirus |
WO2010138769A1 (fr) * | 2009-05-28 | 2010-12-02 | The United States Government As Represented By The Department Of Veterans Affairs | Séquences d'acides aminés qui améliorent la solubilité de conjugués peptidiques |
GB0920944D0 (en) | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
US9155795B2 (en) | 2010-02-26 | 2015-10-13 | Anchor Therapeutics, Inc. | CXCR4 receptor compounds |
RU2517084C2 (ru) * | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Способ и средство для ингибирования продукции или усиления элиминации белка р24 |
WO2020008083A1 (fr) * | 2018-07-05 | 2020-01-09 | Consejo Superior De Investigaciones Científicas | Cible thérapeutique dans des récepteurs de chimiokines pour la sélection de composés utiles pour le traitement de processus pathologiques qui impliquent la signalisation de chimiokines |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2250567A1 (fr) * | 1996-03-27 | 1997-10-02 | Gordon Y.K. Ng | Antagonistes recepteurs et transporteurs |
US5939320A (en) * | 1996-05-20 | 1999-08-17 | New York University | G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof |
EP0975749A2 (fr) * | 1996-05-28 | 2000-02-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Recepteur 5 de cc chemokine, anticorps diriges contre ce dernier et animaux transgeniques |
AU735460B2 (en) * | 1996-06-14 | 2001-07-12 | Aaron Diamond Aids Research Center, The | Uses of a chemokine receptor for inhibiting HIV-1 infection |
AU3705097A (en) * | 1996-07-01 | 1998-01-21 | Biosignal Inc. | Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
GB9712818D0 (en) * | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
EP0956290A1 (fr) * | 1996-10-09 | 1999-11-17 | Dana-Farber Cancer Institute | Polypeptides de gp120 possedant des sites de liaison aux recepteurs de la chimiokine a discontinuite de conformation et procedes d'inhibition des infections a vih |
DE69937822T2 (de) * | 1998-02-27 | 2009-01-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | G-protein-gekoppelte rezeptor-antagonisten |
-
2000
- 2000-08-25 AU AU69410/00A patent/AU6941000A/en not_active Abandoned
- 2000-08-25 WO PCT/US2000/023505 patent/WO2001016182A2/fr active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO2001016182A2 (fr) | 2001-03-08 |
WO2001016182A3 (fr) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001241414A1 (en) | Nucleic acids, proteins, and antibodies | |
AU6941000A (en) | Polypeptides that bind hiv gp120 and related nucleic acids, antibodies, compositions, and methods of use | |
AU2001229508A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237947A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241411A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237953A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239726A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001239728A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001241403A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237948A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001237946A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001236459A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001230958A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001243137A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001247190A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001249052A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001249053A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001249054A1 (en) | Nucleic acids, proteins, and antibodies | |
AU2001250767A1 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |